| Catalog Number |
0052-3009 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Code |
Hemorrhage/Blood Loss/Bleeding (1888)
|
| Date of Event |
02/26/2026
|
|
Type of Reportable Event
|
Death
|
|
Additional Manufacturer Narrative
|
|
The impella device has not been received from the customer.Therefore, investigation of the device is not possible.Should the device or any new information be received, a supplemental mdr will be filed.
|
| |
|
Event or Problem Description
|
|
An impella 5.5 device was inserted via the right axillary artery in a 64 year-old male patient presenting with acute myocardial infarction complicated by cardiogenic shock (ami/cgs), scai shock stage d, with a history of known coronary artery disease (cad) and renal insufficiency.The patient underwent impella 5.5 placement in the operating room, and a jp drain was placed, which demonstrated ongoing drainage.The patient received 1 unit of packed red blood cells (prbcs).The anticoagulation level was found to be high, prompting the care team to stop heparin, after which the bleeding stopped.Heparin was later restarted at a lower dose.The patient remained on support.The reported major bleed requiring blood transfusion and hemostasis is consistent with access-site complications and the anticoagulation/purge requirements associated with impella support.The bleeding was resolved with standard intervention.
|
| |
|
Additional Manufacturer Narrative
|
|
Updated information: b2 selected death and added date of death.H1 changed to death.H6 impact code added f02.
|
| |
|
Additional Manufacturer Narrative
|
|
Explant date was provided therefore d6b was updated.
|
| |
|
Additional Manufacturer Narrative
|
|
Major bleed/access site adverse event: the cause of major bleed/access site adverse event was most likely use related since the clinical team confirmed the bleeding was resolved after stopping heparin.
|
| |
|
Search Alerts/Recalls
|